This content is from: Trademarks

Octogen doctrine dealt damaging blow

A decision by a UDRP panellist that again rejects the so-called Octogen line of thinking on bad faith has raised doubts about the sustainability of the doctrine

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.

REQUEST ACCESS

Are you already an Managing IP subscriber? Login here

Related

Instant access to all of our content. Membership Options | 30 Day Trial